Investigation of the Characteristics of Chronic Pain Developing After COVID-19 in Patients With COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 776
- 试验地点
- 1
- 主要终点
- Self-Leeds Assessment of Neuropathic Symptoms & Signs (S-LANSS) Pain Score
研究概览
简要总结
Data on pain after COVID-19 were generally collected from hospitalized patients and only include information on acute pain conditions. However, the characteristics of the chronic pain experienced after COVID-19 are unknown. For this reason, the treatment and recommendations for patients who present with chronic pain after COVID-19 are not clear. Our goal is to determine the characteristics and risk factors of chronic pain developing in COVID-19 patients and to create specific treatment recommendations for these patient groups with further studies.
详细描述
Data on pain developing after COVID-19 were generally collected from hospitalized patients and only include information on acute pain conditions seen after the ilness. It is noteworthy that headache and musculoskeletal pain were seen common in first few weeks. However, the characteristics (mechanical, inflammatory, central sensitization, anxiety-related, etc.) of the chronic pain experienced are unknown. For this reason, the treatment and recommendations for patients who present with chronic pain after COVID-19 are not clear. Our goal is to determine the characteristics and risk factors of chronic pain developing in COVID-19 patients and to create specific treatment recommendations for these patient groups with further studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Being over the age of 18
- •SARS-CoV-2 infection demonstrated with the PCR test (testing date irrelevant)
- •Pain developed or increased after having COVID-19
排除标准
- •Mental retardation or mental status not eligible to answer the questionnaires
结局指标
主要结局
Self-Leeds Assessment of Neuropathic Symptoms & Signs (S-LANSS) Pain Score
时间窗: up to 1 year
The S-LANSS aims to identify pain of predominantly neuropathic origin, as distinct from nociceptive pain, without the need for clinical examination.
The Hospital Anxiety and Depression Scale (HADS) Score
时间窗: up to 1 year
The Hospital Anxiety and Depression Scale (HADS) is a self-assessment questionnaire that has been found to be a reliable instrument for detecting states of anxiety and depression in the setting of hospital outpatient clinic. The HADS questionnaire has seven items each for depression and anxiety subscales.
Central Sensitization Inventory (CSI)
时间窗: up to 1 year
The Central Sensitisation Inventory (CSI) is a self-report outcome measure designed to identify patients who have symptoms that may be related to central sensitisation (CS) or central sensitivity syndromes (CSS) such as fibromyalgia, neck injury, temporomandibular joint disorder or migraine/tension headaches. CSI includes 25 questions related to common CSS symptoms.
Visual Analog Scale (VAS) for Pain
时间窗: up to 1 year
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."
Self-report Demographic Questionnaire
时间窗: up to 1 year
A questionnaire made by the researchers to understand the demographic characteristics of the patients included.
次要结局
未报告次要终点
研究者
Mert Zure
Medical Doctor
Istanbul University